Ina-Maria Harweth

Title: The Innovative Contributions of Ina-Maria Harweth

Introduction

Ina-Maria Harweth is a notable inventor based in Grenzach-Wyhlen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. Her work has implications for the diagnosis and treatment of tumors, showcasing her commitment to advancing medical science.

Latest Patents

Ina-Maria Harweth holds a patent for "Recombinant antibodies specific for a growth factor receptor." This invention involves recombinant antibodies directed to the extracellular domain of the human growth factor receptor c-erbB-2. The patent encompasses a light chain variable domain and a heavy chain variable domain of a monoclonal antibody. It also includes monoclonal antibodies directed to c-erbB-2, methods for manufacturing these antibodies, hybridoma cells that secrete them, and various processes for using these antibodies in medical applications.

Career Highlights

Ina-Maria Harweth is associated with Ciba-Geigy Corporation, where she has been able to apply her expertise in biotechnology. Her career reflects a dedication to research and innovation, particularly in the area of cancer treatment.

Collaborations

Throughout her career, Ina-Maria has collaborated with esteemed colleagues such as Winfried Stephan Wels and Nancy E. Hynes. These collaborations have further enriched her research and contributed to the advancement of her projects.

Conclusion

Ina-Maria Harweth's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to impact the medical field positively, particularly in cancer diagnosis and treatment.